Matt Sause elevated as new CEO of Roche Diagnostics
Sause will become CEO Roche Diagnostics and a member of the Corporate Executive Committee effective 1 January 2023.
Sause will become CEO Roche Diagnostics and a member of the Corporate Executive Committee effective 1 January 2023.
Roche will pay a purchase price of USD 295 million and an additional payment of up to USD 55 million
Almost 300 million people globally have chronic hepatitis B
Subscribe To Our Newsletter & Stay Updated